Efficacy of Microneedle Fractional Radiofrequency Combined With Topical Insulin for the Treatment of Facial Atrophic Acne Scars: A Split‐Face, Double‐Blinded, Randomized, Placebo‐Controlled Trial
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70033 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Teerapong Rattananukrom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Acne Vulgaris, Cicatrix, Insulin, Radiofrequency Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Topical insulin (TI) has been shown to enhance wound healing by promoting re‐epithelialization and collagen synthesis. However, there have been limited studies addressing its potential use in treating acne scars.
Objectives
To assess the efficacy of combining TI with microneedle fractional radiofrequency (MFR) in the treatment of atrophic acne scars. Materials and Method A split‐face, double‐blinded, placebo‐controlled trial involved 30 participants with atrophic acne scars. Each side of the participants' face was randomly treated with a combination of MFR and TI or a placebo every 4 weeks for four consecutive sessions.
Results
Significant improvements in scar volume were observed, with statistical significance at week 12 for MFR combined with TI sides (baseline 18.22 ± 9.86 vs. 16.20 ± 8.58 mm 3 , p = 0.017) and at week 16 for MFR combined with placebo sides (baseline 18.02 ± 9.24 vs. 15.28 ± 8.21 mm 3 , p = 0.001). The TI sides exhibited a reduction of 46.77% ± 21.33% in Echelle d’ évaluation clinique des cicatrices d’ acne (ECCA) ( p ≤ 0.001), while the placebo sides showed a reduction of 46.39% ± 20.14% in ECCA ( p ≤ 0.001). There were no significant differences in melanin, and hemoglobin index between the two groups. No hypoglycemic symptoms were reported.
Conclusion
Combining topical insulin with MFR is safe and could accelerate the early acne scar improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
ORCID-Profile: Teerapong Rattananukrom, Cherrin Pomsoong, Vasanop Vachiramon
Zitieren
APA
Rattananukrom, T., Tejapira, K., Pomsoong, C., Ratanapokasatit, Y., & Vachiramon, V. (2025). Efficacy of Microneedle Fractional Radiofrequency Combined With Topical Insulin for the Treatment of Facial Atrophic Acne Scars: A Split‐Face, Double‐Blinded, Randomized, Placebo‐Controlled Trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70033
Vancouver
Rattananukrom T, Tejapira K, Pomsoong C, Ratanapokasatit Y, Vachiramon V. Efficacy of Microneedle Fractional Radiofrequency Combined With Topical Insulin for the Treatment of Facial Atrophic Acne Scars: A Split‐Face, Double‐Blinded, Randomized, Placebo‐Controlled Trial. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70033
BibTeX
@article{Rattananukrom2025,
author = {Rattananukrom, Teerapong and Tejapira, Kasama and Pomsoong, Cherrin and Ratanapokasatit, Yanisa and Vachiramon, Vasanop},
title = {Efficacy of Microneedle Fractional Radiofrequency Combined With Topical Insulin for the Treatment of Facial Atrophic Acne Scars: A Split‐Face, Double‐Blinded, Randomized, Placebo‐Controlled Trial},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70033}
}
EUVIMED